Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE)
1_MGSSR 6_ LAALL 11_ LPLLL 16_ IVIDL 21_ SDSAG 26_ IGFRH 31_ LPHWN 36_ TRCPL 41_ ASHTD 46_ DSFTG 51_ SSAYI 56_ PCRTW 61_ WALFS 66_ TKPWC 71_ VRVWH 76_ CSRCL 81_ CQHLL 86_ SGGSG 91_ LQRGL 96_ FHLLV 101_ QKSKK 106_ SSTFK 111_ FYRRH 116_ KMPAP 121_ AQRKL 126_ LPRRH 131_ LSEKS 136_ HHISI 141_ PSPDI 146_ SHKGL 151_ RSKRT 156_ QPSDP 161_ ETWES 166_ LPRLD 171_ SQRHG 176_ GPEFS 181_ FDLLP 186_ EARAI 191_ RVTIS 196_ SGPEV 201_ SVRLC 206_ HQWAL 211_ ECEEL 216_ SSPYD 221_ VQKIV 226_ SGGHT 231_ VELPY 236_ EFLLP 241_ CLCIE 246_ ASYLQ 251_ EDTVR 256_ RKKCP 261_ FQSWP 266_ EAYGS 271_ DFWKS 276_ VHFTD 281_ YSQHT 286_ QMVMA 291_ LTLRC 296_ PLKLE 301_ AALCQ 306_ RHDWH 311_ TLCKD 316_ LPNAT 321_ ARESD 326_ GWYVL 331_ EKVDL 336_ HPQLC 341_ FKFSF 346_ GNSSH 351_ VECPH 356_ QTGSL 361_ TSWNV 366_ SMDTQ 371_ AQQLI 376_ LHFSS 381_ RMHAT 386_ FSAAW 391_ SLPGL 396_ GQDTL 401_ VPPVY 406_ TVSQA 411_ RGSSP 416_ VSLDL 421_ IIPFL 426_ RPGCC 431_ VLVWR 436_ SDVQF 441_ AWKHL 446_ LCPDV 451_ SYRHL 456_ GLLIL 461_ ALLAL 466_ LTLLG 471_ VVLAL 476_ TCRRP 481_ QSGPG 486_ PARPV 491_ LLLHA 496_ ADSEA 501_ QRRLV 506_ GALAE 511_ LLRAA 516_ LGGGR 521_ DVIVD 526_ LWEGR 531_ HVARV 536_ GPLPW 541_ LWAAR 546_ TRVAR 551_ EQGTV 556_ LLLWS 561_ GADLR 566_ PVSGP 571_ DPRAA 576_ PLLAL 581_ LHAAP 586_ RPLLL 591_ LAYFS 596_ RLCAK 601_ GDIPP 606_ PLRAL 611_ PRYRL 616_ LRDLP 621_ RLLRA 626_ LDARP 631_ FAEAT 636_ SWGRL 641_ GARQR 646_ RQSRL 651_ ELCSR 656_ LEREA 661_ARLAD
1: Specific functional receptor for IL17C. May be signaling through the NF-kappa-B and MAPK pathways. May require TRAF3IP2 /ACT1 for signaling. May be a crucial regulator in innate immunity to bacterial pathogens. Isoform 2 and isoform 4 may be either cytoplasmic inactive or dominant active forms. Isoform 3 and isoform 5 may act as soluble decoy receptors